CORONA VIRUS INFECTION

This early-stage study tested three new self-amplifying RNA vaccines against COVID-19 in 72 healthy adults, some already vaccinated and some not. Researchers checked for side effects and measured immune responses, including against virus variants. The goal was to see if these vac…

This study tested the CoviVac COVID-19 vaccine in 200 healthy adults aged 60 and older. Researchers checked how safe the vaccine was and how well it boosted the immune system. The goal was to see if the vaccine could help prevent COVID-19 in this age group.

This study tested whether giving early treatment to adults with COVID-19 who have risk factors (like age over 60 or high blood pressure) could prevent them from needing oxygen, hospitalization, or dying. About 412 people took part. The goal was to see if these treatments are safe…

This study tested whether adding the drug AZD7442 to standard care helps hospitalized adults with COVID-19 recover faster. About 1,500 participants received either the drug or a placebo. The main goal was to see how their symptoms changed over time, from being able to do normal a…

This early-stage study tested a new drug called SIR1-365 in 45 hospitalized adults with severe COVID-19. The main goal was to see if the drug is safe and tolerable. Researchers also looked at whether it could reduce inflammation and improve patient outcomes. The trial was complet…

This study tested whether the drug sarilumab could help adults hospitalized with severe or critical COVID-19 recover faster. About 420 participants received either sarilumab or a placebo. The main goal was to see if sarilumab improved clinical status within 28 days. The trial fou…

This early-stage study tested an experimental drug called SAR443122 in 68 hospitalized adults with severe COVID-19. The goal was to see if the drug could safely reduce dangerous inflammation, measured by a blood marker called C-reactive protein. Participants received either the d…

This study created a global registry to track how COVID-19 affects kidney function in 500 patients. Researchers aimed to find out how often kidney damage occurs and who is most at risk. The goal is to better understand the disease and guide future treatments.

This study followed 211 older adults who were hospitalized with COVID-19 to see how their ability to move and do daily activities changed over time. Researchers measured mobility, thinking skills, and frailty after discharge. The goal is to understand recovery patterns and help d…

This study looked at children and young adults under 24 who had COVID-19, including those with cancer. Researchers collected samples and medical information to learn about symptoms, risk factors, and how the virus spreads. The goal was to better understand the disease in younger …

This study looked at over 1,000 adults with COVID-19 who were sick enough to need intensive care in French hospitals. Researchers collected information on how these patients were treated and what complications they had. The goal was to understand what factors affect their recover…

This study looked at whether it is safe to give another dose of a COVID-19 mRNA vaccine to people who had a bad reaction to a previous dose, or to people with a history of allergies. It also included people with long COVID. A total of 137 adults took part and received either the …

This study looked at nearly 2,000 adults with lung cancer who caught COVID-19. Researchers tracked their health and checked for antibodies (immune system markers) right after infection and again 6 months after vaccination. The goal was to understand how lung cancer affects the bo…

This study looked at how the immune system's T-cells fight the COVID-19 virus in 51 hospitalized patients and healthy hospital staff. Researchers measured T-cell activity over time to understand how the body builds immunity. The goal was to learn more about the immune response, n…